Enhanced Lymphatic Delivery of Methotrexate Using W/O/W Nanoemulsion: In Vitro Characterization and Pharmacokinetic Study.
TLDR
The prepared nanoemulsion showed significant increases in maximum plasma concentration, area under the plasma concentration-time curve, half-life, oral bioavailability, and lymphatic targeting efficiency in both oral and intravenous administration.Abstract:
Methotrexate, which is widely used in the treatment of cancer and immune-related diseases, has limitations in use because of its low bioavailability, short half-life, and tissue toxicity. Thus, in this study, a nano-sized water-in-oil-in-water (W/O/W) double emulsion containing methotrexate was prepared to enhance its lymphatic delivery and bioavailability. Based on the results from solubility testing and a pseudo-ternary diagram study, olive oil as the oil, Labrasol as a surfactant, and ethanol as a co-surfactant, were selected as the optimal components for the nanoemulsion. The prepared nanoemulsion was evaluated for size, zeta potential, encapsulation efficiency, pH, morphology, and in vitro release profiles. Furthermore, pharmacokinetics and lymphatic targeting efficiency were assessed after oral and intravenous administration of methotrexate-loaded nanoemulsion to rats. Mean droplet size, zeta potential, encapsulation efficiency, and pH of formulated nanoemulsion were 173.77 ± 5.76 nm, -35.63 ± 0.78 mV, 90.37 ± 0.96%, and 4.07 ± 0.03, respectively. In vitro release profile of the formulation indicated a higher dissolution and faster rate of methotrexate than that of free drug. The prepared nanoemulsion showed significant increases in maximum plasma concentration, area under the plasma concentration-time curve, half-life, oral bioavailability, and lymphatic targeting efficiency in both oral and intravenous administration. Therefore, our research proposes a methotrexate-loaded nanoemulsion as a good candidate for enhancing targeted lymphatic delivery of methotrexate.read more
Citations
More filters
Recent advances in lymphatic targeted drug delivery system for tumor metastasis
TL;DR: Novel and effective lymphatic targeted drug delivery systems have been explored to improve the specificity of anticancer drugs to tumor cells in lymph nodes and recent advances in the development of lymphatics targeted carriers are discussed.
Journal ArticleDOI
Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy—An Overview on Recent Advances
Shery Jacob,Anroop B. Nair,Jigar Shah,Sumeet Gupta,Sai H.S. Boddu,Nagaraja Sreeharsha,Alex Joseph,Pottathil Shinu,Mohamed A. Morsy +8 more
TL;DR: Functionalization approaches to overcome the drawbacks of lipid nanoparticles, as well as the exploration of new functional additives with the potential to improve the penetration of macromolecular pharmaceuticals, would quickly progress the challenging field of ocular drug delivery systems.
Journal ArticleDOI
Engineering Nano- and Microparticles as Oral Delivery Vehicles to Promote Intestinal Lymphatic Drug Transport.
Yang-Bao Miao,Yu-Jung Lin,Chen Kuan-Hung,Po-Kai Luo,Shun-Hao Chuang,Yu-Tzu Yu,Hsien-Meng Tai,Chiung-Tong Chen,Kun-Ju Lin,Hsing-Wen Sung +9 more
TL;DR: In this paper, the authors describe the anatomical structures and physiological characteristics of the intestinal lymphatic system (ILS), with an emphasis on enterocytes and microfold (M) cells, which are the main gateways for the transport of particulate delivery vehicles across the intestinal epithelium into the lymphatics.
Journal ArticleDOI
Nanocarriers based oral lymphatic drug targeting: Strategic bioavailability enhancement approaches
TL;DR: Various strategies to enhance drug bioavailability through lymphatic targeting are discussed, which can improve the treatment efficacy, survival, and life expectancy of the patient.
Journal ArticleDOI
Oral delivery of topotecan in polymeric nanoparticles: Lymphatic distribution and pharmacokinetics.
TL;DR: In this article, a study was conducted on topotecan-loaded nanoparticles using poly(lactic-co-glycolic acid) (PLGA), which were prepared by double emulsion solvent evaporation.
References
More filters
Journal ArticleDOI
Food-grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity.
TL;DR: An overview of the current status of nanoemulsion formulation, fabrication, properties, applications, biological fate, and potential toxicity with emphasis on systems suitable for utilization within the food and beverage industry is provided.
Journal ArticleDOI
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.
TL;DR: The ideal nanoparticle platform is the one whose integrity is not disturbed in the complex biological environment, which provides extended circulation in the blood to maximize delivery to the target site, is not toxic to blood cellular components, and is "invisible" to the immune cells which can remove it from circulation.
Journal ArticleDOI
Emulsion-based delivery systems for lipophilic bioactive components.
TL;DR: A brief overview of the major bioactive lipids that need to be delivered within the food industry (for example, omega-3 fatty acids, carotenoids, and phytosterols) is provided, highlighting the main challenges to their current incorporation into foods.
Journal ArticleDOI
Nanoemulsions: formation, properties and applications
TL;DR: The major methods to prepare nanoemulsions, theories to predict droplet size, physical conditions and chemical additives which affect droplet stability, and recent applications are summarized.
Journal ArticleDOI
Nanoemulsion: an advanced mode of drug delivery system
TL;DR: This review gives a detailed idea about a nanoemulsion system, in which two immiscible liquids are mixed to form a single phase by means of an emulsifying agent, i.e., surfactant and co-surfactant.